数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

董事介绍

注:董事持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Haim Mer Chairman of the Board of Director 72 8.75万美元 未持股 2020-03-26
Scott Burell Director 55 未披露 未持股 2020-03-26
Isaac Onn Director 68 未披露 未持股 2020-03-26
Varda Trivaks Outside Director 63 未披露 未持股 2020-03-26
Ronen Twito Outside Director 45 未披露 未持股 2020-03-26

高管介绍

注:高管持股数取自最新公司公告

姓名 性别 职位 年龄 薪酬 持股数(万股) 截止日期
Roy Hess Chief Executive Officer 58 39.18万美元 未持股 2020-03-26
Ofira Bar Chief Financial Officer 39 10.14万美元 未持股 2020-03-26
Oren Kaplan VP Sales and Marketing 46 未披露 未持股 2020-03-26

董事简历

中英对照 |  中文 |  英文
Haim Mer

Haim Mer自1995年12月公司成立起担任董事长和董事。Mer自1988年起担任C. Mer Industries Ltd.(一家公开上市公司)董事长;1988年到2005年1月担任总裁和首席执行官。Mer持有the Technion - Israel Institute of Technology计算机科学和数学理学学士学位。


Haim Mer has served as the Chairman of our Board of Directors and a director since our inception in December 1995. Mr. Mer has served as the Chairman of the Board of Directors of C. Mer Industries Ltd., a publicly traded company, since 1988 and served as its President and Chief Executive Officer from 1988 until January 2005. Mr. Mer holds a B.Sc. degree in Computer Sciences and Mathematics from the Technion - Israel Institute of Technology.
Haim Mer自1995年12月公司成立起担任董事长和董事。Mer自1988年起担任C. Mer Industries Ltd.(一家公开上市公司)董事长;1988年到2005年1月担任总裁和首席执行官。Mer持有the Technion - Israel Institute of Technology计算机科学和数学理学学士学位。
Haim Mer has served as the Chairman of our Board of Directors and a director since our inception in December 1995. Mr. Mer has served as the Chairman of the Board of Directors of C. Mer Industries Ltd., a publicly traded company, since 1988 and served as its President and Chief Executive Officer from 1988 until January 2005. Mr. Mer holds a B.Sc. degree in Computer Sciences and Mathematics from the Technion - Israel Institute of Technology.
Scott Burell

Scott Burell在合并后成为Microbot Medical Inc.的董事。自2018年8月1日起,Burell先生一直担任AIVITA Biomedical,Inc.的首席财务官。AIVITA Biomedical,Inc.是一家总部位于加利福尼亚州欧文市的免疫肿瘤公司,专注于利用治疗和再生药物推进商业和临床阶段计划。从2006年11月到2017年11月出售给因维塔公司(NYSE:NVTA),他是CombiMatrix Corporation(NASDAQ:CBMX)的首席财务官、秘书和财务主管。CombiMatrix Corporation是一家专注于家庭健康的临床分子诊断实验室,专门从事植入前基因筛查、产前诊断、流产分析,和儿童发育障碍。2007年,他成功地领导了CombiMatrix与其前母公司的分拆,并领导了几次成功的公共和私人债务及股权融资交易,以及CombiMatrix在2010年的重组。在此之前,Burell先生自2001年11月起担任CombiMatrix的财务副总裁,并于2001年2月至2001年11月担任其财务总监。从1999年5月至2001年2月首次加入CombiMatrix,Burell先生担任Network Commerce,Inc.(纳斯达克:SPNW)的财务总监,位于西雅图的一家公开交易的技术和信息基础设施公司。在此之前,Burell先生在西雅图安达信审计和商业咨询事务所工作了九年。在担任公共会计期间,Burell先生在高科技和医疗市场与许多公共和私人客户合作,并参与了大量公开发行、分拆、合并和收购。Burell先生于1992年获得华盛顿州注册会计师执照,是一名注册会计师(目前不在职)。他拥有中央华盛顿大学会计和商业金融学理学学士学位。


Scott Burell,became a director of the Company following the Merger. Since August 1, 2018, Mr. Burell has been the Chief Financial Officer and Secretary of AIVITA Biomedical, Inc., an Irvine California-based immuno-oncology company focused on the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. From November 2006 until its sale to Invitae Corp. (NASDAQ: NVTA) in November 2017, he was the Chief Financial Officer, Secretary and Treasurer of CombiMatrix Corporation (NASDAQ: CBMX), a family health-focused clinical molecular diagnostic laboratory specializing in pre-implantation genetic screening, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. He successfully led the split-off of CombiMatrix in 2007 from its former parent, has led several successful public and private debt and equity financing transactions as well as CombiMatrix's reorganization in 2010. Prior to this, Mr. Burell had served as CombiMatrix's Vice President of Finance since November 2001 and as its Controller from February 2001 to November 2001. From May 1999 to first joining CombiMatrix in February 2001, Mr. Burell was the Controller for Network Commerce, Inc. (NASDAQ: SPNW), a publicly traded technology and information infrastructure company located in Seattle. Prior to this, Mr. Burell spent nine years with Arthur Andersen's Audit and Business Advisory practice in Seattle. During his tenure in public accounting, Mr. Burell worked with many clients, both public and private, in the high-tech and healthcare markets, and was involved in numerous public offerings, spin-offs, mergers and acquisitions. Mr. Burell obtained his Washington state CPA license in 1992 and is a certified public accountant (currently inactive). He holds Bachelor of Science degrees in Accounting and Business Finance from Central Washington University.
Scott Burell在合并后成为Microbot Medical Inc.的董事。自2018年8月1日起,Burell先生一直担任AIVITA Biomedical,Inc.的首席财务官。AIVITA Biomedical,Inc.是一家总部位于加利福尼亚州欧文市的免疫肿瘤公司,专注于利用治疗和再生药物推进商业和临床阶段计划。从2006年11月到2017年11月出售给因维塔公司(NYSE:NVTA),他是CombiMatrix Corporation(NASDAQ:CBMX)的首席财务官、秘书和财务主管。CombiMatrix Corporation是一家专注于家庭健康的临床分子诊断实验室,专门从事植入前基因筛查、产前诊断、流产分析,和儿童发育障碍。2007年,他成功地领导了CombiMatrix与其前母公司的分拆,并领导了几次成功的公共和私人债务及股权融资交易,以及CombiMatrix在2010年的重组。在此之前,Burell先生自2001年11月起担任CombiMatrix的财务副总裁,并于2001年2月至2001年11月担任其财务总监。从1999年5月至2001年2月首次加入CombiMatrix,Burell先生担任Network Commerce,Inc.(纳斯达克:SPNW)的财务总监,位于西雅图的一家公开交易的技术和信息基础设施公司。在此之前,Burell先生在西雅图安达信审计和商业咨询事务所工作了九年。在担任公共会计期间,Burell先生在高科技和医疗市场与许多公共和私人客户合作,并参与了大量公开发行、分拆、合并和收购。Burell先生于1992年获得华盛顿州注册会计师执照,是一名注册会计师(目前不在职)。他拥有中央华盛顿大学会计和商业金融学理学学士学位。
Scott Burell,became a director of the Company following the Merger. Since August 1, 2018, Mr. Burell has been the Chief Financial Officer and Secretary of AIVITA Biomedical, Inc., an Irvine California-based immuno-oncology company focused on the advancement of commercial and clinical-stage programs utilizing curative and regenerative medicines. From November 2006 until its sale to Invitae Corp. (NASDAQ: NVTA) in November 2017, he was the Chief Financial Officer, Secretary and Treasurer of CombiMatrix Corporation (NASDAQ: CBMX), a family health-focused clinical molecular diagnostic laboratory specializing in pre-implantation genetic screening, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. He successfully led the split-off of CombiMatrix in 2007 from its former parent, has led several successful public and private debt and equity financing transactions as well as CombiMatrix's reorganization in 2010. Prior to this, Mr. Burell had served as CombiMatrix's Vice President of Finance since November 2001 and as its Controller from February 2001 to November 2001. From May 1999 to first joining CombiMatrix in February 2001, Mr. Burell was the Controller for Network Commerce, Inc. (NASDAQ: SPNW), a publicly traded technology and information infrastructure company located in Seattle. Prior to this, Mr. Burell spent nine years with Arthur Andersen's Audit and Business Advisory practice in Seattle. During his tenure in public accounting, Mr. Burell worked with many clients, both public and private, in the high-tech and healthcare markets, and was involved in numerous public offerings, spin-offs, mergers and acquisitions. Mr. Burell obtained his Washington state CPA license in 1992 and is a certified public accountant (currently inactive). He holds Bachelor of Science degrees in Accounting and Business Finance from Central Washington University.
Isaac Onn

Isaac Onn自2018年10月31日起担任董事。Onn先生是以色列特拉维夫Eitan Onn Law Offices的成员。Onn从2001年到2008年担任E.P.A.Fuel Services Ltd.首席执行官和合伙人。Onn先生目前也是Cybra Corporation的外部董事和ActiveCare Inc.的董事会成员。OTCMKTS:ACARQ,Intellect Neurosciences,Inc.(OTCMKTS:ILNS),以色列Ness Energy,见世界卫星,NaturalNano,Inc.和Harrison Vickers&Waterman Inc.。Onn先生在特拉维夫管理学院(Tel-Aviv College of Management)获得营销管理学位,并在以色列小野学术法学院(Ono Academic Law School)获得法学学士学位。Onn先生是以色列律师协会的成员。


Isaac Onn has served as a director since October 31 2018. Mr. Onn is a member of Eitan Onn Law Offices in Tel Aviv, Israel. Mr. Onn served as the Chief Executive Officer and a partner of E.P.A. Fuel Services Ltd., from 2001 to 2008. Mr. Onn is also currently an outside director of CYBRA Corporation and a board member of ActiveCare Inc. OTCMKTS: ACARQ, Intellect Neurosciences, Inc. (OTCMKTS: ILNS), Ness Energy of Israel, See World Satellites, Naturalnano, Inc. and Harrison Vickers & Waterman Inc.. Mr. Onn received his degree in marketing management from the Tel-Aviv College of Management and his LLB, Bachelor of Law degree from Ono Academic Law School in Israel. Mr. Onn is a member of the Israel Bar Association.
Isaac Onn自2018年10月31日起担任董事。Onn先生是以色列特拉维夫Eitan Onn Law Offices的成员。Onn从2001年到2008年担任E.P.A.Fuel Services Ltd.首席执行官和合伙人。Onn先生目前也是Cybra Corporation的外部董事和ActiveCare Inc.的董事会成员。OTCMKTS:ACARQ,Intellect Neurosciences,Inc.(OTCMKTS:ILNS),以色列Ness Energy,见世界卫星,NaturalNano,Inc.和Harrison Vickers&Waterman Inc.。Onn先生在特拉维夫管理学院(Tel-Aviv College of Management)获得营销管理学位,并在以色列小野学术法学院(Ono Academic Law School)获得法学学士学位。Onn先生是以色列律师协会的成员。
Isaac Onn has served as a director since October 31 2018. Mr. Onn is a member of Eitan Onn Law Offices in Tel Aviv, Israel. Mr. Onn served as the Chief Executive Officer and a partner of E.P.A. Fuel Services Ltd., from 2001 to 2008. Mr. Onn is also currently an outside director of CYBRA Corporation and a board member of ActiveCare Inc. OTCMKTS: ACARQ, Intellect Neurosciences, Inc. (OTCMKTS: ILNS), Ness Energy of Israel, See World Satellites, Naturalnano, Inc. and Harrison Vickers & Waterman Inc.. Mr. Onn received his degree in marketing management from the Tel-Aviv College of Management and his LLB, Bachelor of Law degree from Ono Academic Law School in Israel. Mr. Onn is a member of the Israel Bar Association.
Varda Trivaks

Varda Trivaks,她担任公司外部董事(2008年8月以来),是Sharplink Gaming Ltd.审计委员会的一员。她于2001与他人共同创立Mimtar Business Consulting公司,并担任总经理。她负责公司投资、合并、分拆、估值、控制、预算的咨询,特别注重重组和复苏的时期的咨询全球公司和管理公司。她是Plastic Products公司和E. Schnapp & Co. Works公司的审计委员会,董事会和/或金融委员会的成员。从1998年到2004年,她是the Israel Accounting Institute的资本市场和保险通信委员会的成员。从1998年到2001年,她担任 Shlomo Ziv and Co. - BDO公司(会计和咨询公司合作)的合伙人,以及其子公司的董事总经理。她是一个以色列注册会计师(自1987年以来),拥有特拉维夫大学(Tel Aviv University)的经济和会计学学士学位,以及波士顿大学(Boston University)的管理硕士学位。


Varda Trivaks has served as an outside director since August 2008 and is the chairwoman of Sharplink Gaming Ltd. audit and compensation committees. Ms. Trivaks serves as the Managing Director and is one of the two founding partners of Mimtar Business Consulting, established in 2001. In that position, Ms. Trivaks acts as an advisor to companies on investments, mergers, spin-offs, valuation, control, budgeting, with a special focus on advising global companies and management of companies during times of restructuring and recovery. Ms. Trivaks serves as a member of the audit committee, board of directors and financial committee of Halamish - Municipal Government Company for housing and neighborhood renewal in Tel Aviv Jaffa Ltd. Previously served as a member of the board of directors and audit, balance sheet and compensation committees of E. Schnapp & Co. Works and of Ginegar Plastic Products Ltd. From 1998 to 2004 Ms. Trivaks was a member of the Israel Accounting Institute's communications committee for Capital Markets and Insurance. From 1998 to 2001 Ms. Trivaks was a partner with the accounting and consulting firm, BDO, and served as the managing director of one of its subsidiaries. Ms. Trivaks is a Certified Public Accountant Israel since 1987 and holds a B.A. degree in Economics and Accounting from Tel Aviv University and a Master of Science in Management degree from Boston University.
Varda Trivaks,她担任公司外部董事(2008年8月以来),是Sharplink Gaming Ltd.审计委员会的一员。她于2001与他人共同创立Mimtar Business Consulting公司,并担任总经理。她负责公司投资、合并、分拆、估值、控制、预算的咨询,特别注重重组和复苏的时期的咨询全球公司和管理公司。她是Plastic Products公司和E. Schnapp & Co. Works公司的审计委员会,董事会和/或金融委员会的成员。从1998年到2004年,她是the Israel Accounting Institute的资本市场和保险通信委员会的成员。从1998年到2001年,她担任 Shlomo Ziv and Co. - BDO公司(会计和咨询公司合作)的合伙人,以及其子公司的董事总经理。她是一个以色列注册会计师(自1987年以来),拥有特拉维夫大学(Tel Aviv University)的经济和会计学学士学位,以及波士顿大学(Boston University)的管理硕士学位。
Varda Trivaks has served as an outside director since August 2008 and is the chairwoman of Sharplink Gaming Ltd. audit and compensation committees. Ms. Trivaks serves as the Managing Director and is one of the two founding partners of Mimtar Business Consulting, established in 2001. In that position, Ms. Trivaks acts as an advisor to companies on investments, mergers, spin-offs, valuation, control, budgeting, with a special focus on advising global companies and management of companies during times of restructuring and recovery. Ms. Trivaks serves as a member of the audit committee, board of directors and financial committee of Halamish - Municipal Government Company for housing and neighborhood renewal in Tel Aviv Jaffa Ltd. Previously served as a member of the board of directors and audit, balance sheet and compensation committees of E. Schnapp & Co. Works and of Ginegar Plastic Products Ltd. From 1998 to 2004 Ms. Trivaks was a member of the Israel Accounting Institute's communications committee for Capital Markets and Insurance. From 1998 to 2001 Ms. Trivaks was a partner with the accounting and consulting firm, BDO, and served as the managing director of one of its subsidiaries. Ms. Trivaks is a Certified Public Accountant Israel since 1987 and holds a B.A. degree in Economics and Accounting from Tel Aviv University and a Master of Science in Management degree from Boston University.
Ronen Twito

Ronen Twito自2015年11月以来担任我们的副首席执行官兼首席财务官。在加入我们之前,从2014年至2015年,他担任BioBlast Pharma Ltd. (NASDAQ: ORPN)的副总裁,一家从事于针对稀有罕见的遗传性疾病的临床阶段的生物技术开发公司。自2009年至2014年,Mr. Twito担任一家着重后期临床开发的公司XTL Biopharmaceuticals,或者称作为XTL (NASDAQ: XTLB)的副首席执行官兼首席财务官。在2012年至2013年,Mr. Twito还担任过InterCure的首席执行官,一家专门从事于FDA批准治疗高血压设备的开发和销售的医疗设备公司(后成为XTL的附属公司)(TASE:INCR)。从2004年至2009年,Mr. Twito担任Leadcom Integrated Solutions Ltd.的公司财务总监,这是一家专门从事于实施与管理网络部署服务的国际电信公司(当时上市的AIM和TASE)。此前,他曾担任Ernst & Young Israel的审计经理。Mr. Twito是以色列的注册会计师,并是以色列注册会计师研究所成员。他拥有商业管理和会计的学士学位,在以色列Collman Management College担任会计的教学。


Ronen Twito has served as an outside director since March 2019 and is a member of our audit and compensation committees. Mr. Twito is the founder of Amplify Capital Ltd., an Israeli corporate finance services firm, and has worked there since its founding in 2017. Mr. Twito served as the deputy CEO & CFO of Cellect Biotechnology Ltd. NASDAQ: APOP from November 2015 to January 2017. Prior to that he served as VP finance of BioBlast Pharma Ltd. (NASDAQ: ORPN) from April 2014 to November 2015. From July 2009 to April 2014 he served as the CFO of XTL Biopharmaceuticals Ltd. (NASDAQ; TASE: XTLB) and also served as its deputy CEO from April 2012 to April 2014. Mr. Twito served also as a deputy CEO of InterCure Ltd (TASE: INCR) since July 2012 and CEO since November 2012. Prior that, he served as Corporate Finance Director at Leadcom Integrated Solutions Ltd., an international telecommunications company, specializing in management and implementation of network deployment services (then listed on the AIM and TASE) from November 2004 to May 2009. Previously he served as an Audit Manager at Ernst & Young (EY) from January 2000 to November 2004. Mr. Twito possesses over 19 years of finance and management experience in both publicly traded and private companies, which includes IPOs, dual listings, bonds placement, private placements and M&As. Mr. Twito is an Israeli Certified Public Accountant and is a member of the Institute of CPAs in Israel. He holds a B.A. in Business & Management - Accounting, and a B.Ed. degree in teaching accounting, both from the Collman Management College.
Ronen Twito自2015年11月以来担任我们的副首席执行官兼首席财务官。在加入我们之前,从2014年至2015年,他担任BioBlast Pharma Ltd. (NASDAQ: ORPN)的副总裁,一家从事于针对稀有罕见的遗传性疾病的临床阶段的生物技术开发公司。自2009年至2014年,Mr. Twito担任一家着重后期临床开发的公司XTL Biopharmaceuticals,或者称作为XTL (NASDAQ: XTLB)的副首席执行官兼首席财务官。在2012年至2013年,Mr. Twito还担任过InterCure的首席执行官,一家专门从事于FDA批准治疗高血压设备的开发和销售的医疗设备公司(后成为XTL的附属公司)(TASE:INCR)。从2004年至2009年,Mr. Twito担任Leadcom Integrated Solutions Ltd.的公司财务总监,这是一家专门从事于实施与管理网络部署服务的国际电信公司(当时上市的AIM和TASE)。此前,他曾担任Ernst & Young Israel的审计经理。Mr. Twito是以色列的注册会计师,并是以色列注册会计师研究所成员。他拥有商业管理和会计的学士学位,在以色列Collman Management College担任会计的教学。
Ronen Twito has served as an outside director since March 2019 and is a member of our audit and compensation committees. Mr. Twito is the founder of Amplify Capital Ltd., an Israeli corporate finance services firm, and has worked there since its founding in 2017. Mr. Twito served as the deputy CEO & CFO of Cellect Biotechnology Ltd. NASDAQ: APOP from November 2015 to January 2017. Prior to that he served as VP finance of BioBlast Pharma Ltd. (NASDAQ: ORPN) from April 2014 to November 2015. From July 2009 to April 2014 he served as the CFO of XTL Biopharmaceuticals Ltd. (NASDAQ; TASE: XTLB) and also served as its deputy CEO from April 2012 to April 2014. Mr. Twito served also as a deputy CEO of InterCure Ltd (TASE: INCR) since July 2012 and CEO since November 2012. Prior that, he served as Corporate Finance Director at Leadcom Integrated Solutions Ltd., an international telecommunications company, specializing in management and implementation of network deployment services (then listed on the AIM and TASE) from November 2004 to May 2009. Previously he served as an Audit Manager at Ernst & Young (EY) from January 2000 to November 2004. Mr. Twito possesses over 19 years of finance and management experience in both publicly traded and private companies, which includes IPOs, dual listings, bonds placement, private placements and M&As. Mr. Twito is an Israeli Certified Public Accountant and is a member of the Institute of CPAs in Israel. He holds a B.A. in Business & Management - Accounting, and a B.Ed. degree in teaching accounting, both from the Collman Management College.

高管简历

中英对照 |  中文 |  英文
Roy Hess

Roy Hess自2017年10月起担任我们的首席执行官。Hess先生是一位经验丰富的高管,在电信和通信解决方案和服务领域拥有超过20年的成功的全球业务经验。在加入MTS之前,Hess先生从2012年开始担任Bioness Neuromedulation Ltd.的总经理,这是一家医疗设备提供商。在此之前,Hess先生担任Gilat Satcom Systems Ltd.的首席执行官,从2007年到2011年担任C.Mer Industries Ltd.的业务开发副总裁,从2003年到2007年担任Mer Inc.的首席执行官,从1996年到2003年担任Mer Telemanagement Solutions Inc.的总裁。Hess先生拥有学士学位。Ben Gurion University物理学和计算机科学学位以及Tel Aviv University工商管理硕士学位。


Roy Hess has served as our Chief Executive Officer since October 2017. Mr. Hess is a seasoned executive with over 20 years of experience building successful global businesses in the telecom and communication solutions and services sector. Prior to joining MTS, Mr. Hess served as the General Manager of Bioness Neuromodulation Ltd., a provider of medical devices, from 2012. Prior to that, Mr. Hess served as the CEO of Gilat Satcom Systems Ltd., a publicly traded company from 2007 until 2011 as the VP Business Development of C. Mer Industries Ltd. and the CEO of Mer Inc. from 2003 until 2007 and as the President of Mer Telemanagement Solutions Inc. from 1996 until 2003. Mr. Hess holds a B.Sc. degree in Physics and Computer Science from Ben Gurion University and M.B.A. degree from Tel Aviv University.
Roy Hess自2017年10月起担任我们的首席执行官。Hess先生是一位经验丰富的高管,在电信和通信解决方案和服务领域拥有超过20年的成功的全球业务经验。在加入MTS之前,Hess先生从2012年开始担任Bioness Neuromedulation Ltd.的总经理,这是一家医疗设备提供商。在此之前,Hess先生担任Gilat Satcom Systems Ltd.的首席执行官,从2007年到2011年担任C.Mer Industries Ltd.的业务开发副总裁,从2003年到2007年担任Mer Inc.的首席执行官,从1996年到2003年担任Mer Telemanagement Solutions Inc.的总裁。Hess先生拥有学士学位。Ben Gurion University物理学和计算机科学学位以及Tel Aviv University工商管理硕士学位。
Roy Hess has served as our Chief Executive Officer since October 2017. Mr. Hess is a seasoned executive with over 20 years of experience building successful global businesses in the telecom and communication solutions and services sector. Prior to joining MTS, Mr. Hess served as the General Manager of Bioness Neuromodulation Ltd., a provider of medical devices, from 2012. Prior to that, Mr. Hess served as the CEO of Gilat Satcom Systems Ltd., a publicly traded company from 2007 until 2011 as the VP Business Development of C. Mer Industries Ltd. and the CEO of Mer Inc. from 2003 until 2007 and as the President of Mer Telemanagement Solutions Inc. from 1996 until 2003. Mr. Hess holds a B.Sc. degree in Physics and Computer Science from Ben Gurion University and M.B.A. degree from Tel Aviv University.
Ofira Bar

Ofira Bar自2018年5月起担任我们的首席财务官。在加入本公司之前,Bar女士是H.T.S Market,Ltd.的首席财务官,该公司是一家互联网营销公司,也是eZTD Inc.的公司财务总监。OTCMKTS:EZTD。此外,Bar女士曾担任Kesselman and Kesselman,Certified Public Accountants(ISR。(),普华永道国际有限公司的成员公司。Bar女士拥有特拉维夫大学(Tel Aviv University)的会计和经济学学士学位,并在以色列获得注册会计师执照。


Ofira Bar has served as our Chief Financial Officer since May 2018. Prior to joining our company, Ms. Bar was chief financial officer of H.T.S Market, Ltd., an internet marketing firm and corporate controller of EZTD Inc. OTCMKTS: EZTD. In addition, Ms. Bar served as an audit team manager of public and private companies at Kesselman and Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited. Ms. Bar holds a B.A. degree in Accounting and Economics from Tel Aviv University and is licensed as a Certified Public Accountant in Israel.
Ofira Bar自2018年5月起担任我们的首席财务官。在加入本公司之前,Bar女士是H.T.S Market,Ltd.的首席财务官,该公司是一家互联网营销公司,也是eZTD Inc.的公司财务总监。OTCMKTS:EZTD。此外,Bar女士曾担任Kesselman and Kesselman,Certified Public Accountants(ISR。(),普华永道国际有限公司的成员公司。Bar女士拥有特拉维夫大学(Tel Aviv University)的会计和经济学学士学位,并在以色列获得注册会计师执照。
Ofira Bar has served as our Chief Financial Officer since May 2018. Prior to joining our company, Ms. Bar was chief financial officer of H.T.S Market, Ltd., an internet marketing firm and corporate controller of EZTD Inc. OTCMKTS: EZTD. In addition, Ms. Bar served as an audit team manager of public and private companies at Kesselman and Kesselman, Certified Public Accountants (Isr.), a member firm of PricewaterhouseCoopers International Limited. Ms. Bar holds a B.A. degree in Accounting and Economics from Tel Aviv University and is licensed as a Certified Public Accountant in Israel.
Oren Kaplan

Oren Kaplan自2019年9月起担任我们销售与市场营销的副总裁。作为全球销售的Vice President,Oren Kaplan负责MTS的全球销售与市场营销战略。在此之前,卡普兰先生于2017年1月至2018年1月担任物流服务公司Seldat Distribution Inc.的以色列销售与市场营销总监。他于2015年8月和2017年1月担任软件公司Netic Systems Ltd.的营销副总裁,并于2009年8月至2015年8月担任IT服务管理公司NetSource Ltd.的开发部门经理。.Kaplan先生从1997年到2000年在Camera Objumura学习数字媒体传播。


Oren Kaplan has served as our VP Sales and Marketing since September 2019. As Vice President of Global Sales, Oren Kaplan is responsible for MTS's global sales and marketing strategy. Prior to that, Mr. Kaplan served as Israel Sales and Marketing Director of Seldat Distribution Inc., a logistics services company, from January 2017 until January 2018. He served as the VP Marketing of NETIC Systems Ltd., a software company, from August 2015 and January 2017 and served as Development Division Manager for NetSource Ltd., an IT service management company, from August 2009 until August 2015. . Mr. Kaplan studied Digital Media Communication at Camera Obscura from 1997 - 2000.
Oren Kaplan自2019年9月起担任我们销售与市场营销的副总裁。作为全球销售的Vice President,Oren Kaplan负责MTS的全球销售与市场营销战略。在此之前,卡普兰先生于2017年1月至2018年1月担任物流服务公司Seldat Distribution Inc.的以色列销售与市场营销总监。他于2015年8月和2017年1月担任软件公司Netic Systems Ltd.的营销副总裁,并于2009年8月至2015年8月担任IT服务管理公司NetSource Ltd.的开发部门经理。.Kaplan先生从1997年到2000年在Camera Objumura学习数字媒体传播。
Oren Kaplan has served as our VP Sales and Marketing since September 2019. As Vice President of Global Sales, Oren Kaplan is responsible for MTS's global sales and marketing strategy. Prior to that, Mr. Kaplan served as Israel Sales and Marketing Director of Seldat Distribution Inc., a logistics services company, from January 2017 until January 2018. He served as the VP Marketing of NETIC Systems Ltd., a software company, from August 2015 and January 2017 and served as Development Division Manager for NetSource Ltd., an IT service management company, from August 2009 until August 2015. . Mr. Kaplan studied Digital Media Communication at Camera Obscura from 1997 - 2000.